Literature DB >> 27979414

Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.

J K Yamamoto-Furusho1, F Bosques-Padilla2, J de-Paula3, M T Galiano4, P Ibañez5, F Juliao6, P G Kotze7, J L Rocha8, F Steinwurz9, G Veitia10, C Zaltman11.   

Abstract

The incidence and prevalence of inflammatory bowel disease (IBD) has increased in recent years in several Latin American countries. There is a need to raise awareness in gastroenterologists and the population in general, so that early diagnosis and treatment of ulcerative colitis (UC) and Crohn's Disease (CD) can be carried out. It is important for all physicians to have homogeneous criteria regarding the diagnosis and treatment of IBD in Latin America. The Pan American Crohn's and Colitis Organisation (PANCCO) is an organization that aims to include all the countries of the Americas, but it specifically concentrates on Latin America. The present Consensus was divided into two parts for publication: 1) Diagnosis and treatment and 2) Special situations. This is the first Latin American Consensus whose purpose is to promote a perspective adapted to our Latin American countries for the diagnosis, treatment, and monitoring of patients with UC and CD.
Copyright © 2016 Asociación Mexicana de Gastroenterología. Publicado por Masson Doyma México S.A. All rights reserved.

Entities:  

Keywords:  Colitis ulcerosa; Crohn's disease; Diagnosis; Diagnóstico; Enfermedad de Crohn; Enfermedad inflamatoria intestinal; Inflammatory bowel disease; Tratamiento; Treatment; Ulcerative colitis

Mesh:

Year:  2016        PMID: 27979414     DOI: 10.1016/j.rgmx.2016.07.003

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  3 in total

Review 1.  Ophthalmic manifestations in patients with inflammatory bowel disease: A review.

Authors:  Leandro Lopes Troncoso; Ana Luiza Biancardi; Haroldo Vieira de Moraes; Cyrla Zaltman
Journal:  World J Gastroenterol       Date:  2017-08-28       Impact factor: 5.742

2.  Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease.

Authors:  Margarita L Martinez-Fierro; Idalia Garza-Veloz; Maria R Rocha-Pizaña; Edith Cardenas-Vargas; Miguel A Cid-Baez; Fabiola Trejo-Vazquez; Virginia Flores-Morales; Gabriela A Villela-Ramirez; Ivan Delgado-Enciso; Iram P Rodriguez-Sanchez; Yolanda Ortiz-Castro
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

3.  Contemporary surgical practice in the management of anal fistula: results from an international survey.

Authors:  C Ratto; U Grossi; F Litta; G L Di Tanna; A Parello; V De Simone; P Tozer; D DE Zimmerman; Y Maeda
Journal:  Tech Coloproctol       Date:  2019-07-31       Impact factor: 3.781

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.